Data is not available at this time.
Terilogy Holdings Corporation operates in the IT services sector, specializing in IP-network-related and network security solutions for corporate clients in Japan and internationally. The company generates revenue through a diversified model, including hardware and software sales, system consulting, network construction, and maintenance services. Its product portfolio spans routers, switches, WLAN equipment, and advanced security solutions like firewalls and intrusion detection systems, catering primarily to manufacturers and telecommunications carriers. Terilogy distinguishes itself with proprietary offerings such as CloudTriage, a cloud-based performance monitoring service, and EzAvater, a robotic process automation tool, positioning it as a niche player in network infrastructure and cybersecurity. The firm’s focus on SMEs through managed-VPN, web conferencing, and rental server solutions further diversifies its market reach. With a legacy dating back to 1989, Terilogy has established credibility in Japan’s competitive IT services landscape, though its international presence remains limited. The company’s hybrid approach—combining product sales with high-margin services—strengthens its resilience against pure hardware commoditization.
In FY2024, Terilogy reported revenue of ¥6.88 billion, with net income of ¥188.7 million, reflecting a modest net margin of 2.7%. Operating cash flow stood at ¥324.1 million, though capital expenditures of ¥-153 million indicate ongoing investments in infrastructure. The diluted EPS of ¥11.51 suggests efficient capital allocation relative to its market cap, but profitability metrics remain subdued compared to sector peers.
The company’s earnings power is underpinned by recurring service revenue, including maintenance and cloud-based solutions, which likely contribute to stable cash flows. However, its ROIC (Return on Invested Capital) is not disclosed, and the modest net income implies room for improvement in capital efficiency. The low beta of 0.343 suggests earnings are less volatile than the broader market.
Terilogy maintains a robust balance sheet with ¥1.96 billion in cash and equivalents against total debt of ¥369 million, indicating a strong liquidity position. The negligible leverage and high cash reserves provide flexibility for strategic investments or weathering downturns, though the lack of detailed asset breakdowns limits deeper analysis.
Growth appears tepid, with revenue and net income figures suggesting limited recent expansion. The dividend payout of ¥5 per share, while modest, signals a commitment to shareholder returns, though yield calculations are unavailable. The absence of explicit growth catalysts in the data warrants caution.
At a market cap of ¥6.49 billion, Terilogy trades at approximately 0.94x revenue and 34.4x net income, reflecting modest expectations. The low beta implies the market perceives it as a defensive play, but valuation multiples lack context without peer comparisons.
Terilogy’s niche expertise in network security and hybrid service-product offerings provide competitive insulation. However, its reliance on the Japanese market and limited scale pose challenges. The outlook hinges on expanding high-margin services and leveraging CloudTriage’s potential, though macroeconomic pressures in IT spending could constrain near-term growth.
Company description, financial data from disclosed filings, and market metrics from exchange sources.
show cash flow forecast
| Fiscal year | 2026 | 2027 | 2028 | 2029 | 2030 | 2031 | 2032 | 2033 | 2034 | 2035 | 2036 | 2037 | 2038 | 2039 | 2040 | 2041 | 2042 | 2043 | 2044 | 2045 | 2046 | 2047 | 2048 | 2049 | 2050 | |
INCOME STATEMENT | ||||||||||||||||||||||||||
| Revenue growth rate, % | NaN | |||||||||||||||||||||||||
| Revenue, $ | NaN | |||||||||||||||||||||||||
| Variable operating expenses, $m | NaN | |||||||||||||||||||||||||
| Fixed operating expenses, $m | NaN | |||||||||||||||||||||||||
| Total operating expenses, $m | NaN | |||||||||||||||||||||||||
| Operating income, $m | NaN | |||||||||||||||||||||||||
| EBITDA, $m | NaN | |||||||||||||||||||||||||
| Interest expense (income), $m | NaN | |||||||||||||||||||||||||
| Earnings before tax, $m | NaN | |||||||||||||||||||||||||
| Tax expense, $m | NaN | |||||||||||||||||||||||||
| Net income, $m | NaN | |||||||||||||||||||||||||
BALANCE SHEET | ||||||||||||||||||||||||||
| Cash and short-term investments, $m | NaN | |||||||||||||||||||||||||
| Total assets, $m | NaN | |||||||||||||||||||||||||
| Adjusted assets (=assets-cash), $m | NaN | |||||||||||||||||||||||||
| Average production assets, $m | NaN | |||||||||||||||||||||||||
| Working capital, $m | NaN | |||||||||||||||||||||||||
| Total debt, $m | NaN | |||||||||||||||||||||||||
| Total liabilities, $m | NaN | |||||||||||||||||||||||||
| Total equity, $m | NaN | |||||||||||||||||||||||||
| Debt-to-equity ratio | NaN | |||||||||||||||||||||||||
| Adjusted equity ratio | NaN | |||||||||||||||||||||||||
CASH FLOW | ||||||||||||||||||||||||||
| Net income, $m | NaN | |||||||||||||||||||||||||
| Depreciation, amort., depletion, $m | NaN | |||||||||||||||||||||||||
| Funds from operations, $m | NaN | |||||||||||||||||||||||||
| Change in working capital, $m | NaN | |||||||||||||||||||||||||
| Cash from operations, $m | NaN | |||||||||||||||||||||||||
| Maintenance CAPEX, $m | NaN | |||||||||||||||||||||||||
| New CAPEX, $m | NaN | |||||||||||||||||||||||||
| Total CAPEX, $m | NaN | |||||||||||||||||||||||||
| Free cash flow, $m | NaN | |||||||||||||||||||||||||
| Issuance/(repurchase) of shares, $m | NaN | |||||||||||||||||||||||||
| Retained Cash Flow, $m | NaN | |||||||||||||||||||||||||
| Pot'l extraordinary dividend, $m | NaN | |||||||||||||||||||||||||
| Cash available for distribution, $m | NaN | |||||||||||||||||||||||||
| Discount rate, % | NaN | |||||||||||||||||||||||||
| PV of cash for distribution, $m | NaN | |||||||||||||||||||||||||
| Current shareholders' claim on cash, % | NaN |